Clinical trials
Phase 1/2 Oropharyngeal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Christian Hinrichs | 1 |
| Hookipa Biotech GmbH | 1 |
| Hope Cancer Institute, Inc. | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| MedImmune LLC | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oropharyngeal Neoplasms | 19 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Head and Neck Neoplasms | 8 |
| Mouth Neoplasms | 7 |
| Hypopharyngeal Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Anus Neoplasms | 5 |
| Laryngeal Neoplasms | 5 |
| Nasopharyngeal Neoplasms | 4 |
| Salivary Gland Neoplasms | 4 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.